Business Roundup

Clariant has agreed to sell Industrial Park Fechenheim, an industrial park producing and developing chemicals near Frankfurt, Germany, to the real estate firm Lugman Group for $106 million. Clariant intends to use the proceeds from the sale of the park, where it currently has no operations, to reduce its debt.

Brookfield will invest between $200 million and $1.1 billion in the low-carbon fuel maker Infinium. The start-up is building multiple plants that will make jet fuel, diesel, and naphtha from hydrogen and captured carbon dioxide.

EasyMining has won approval from the German government to build a phosphorus recovery plant at a wastewater treatment plant in Schkopau, Germany. The firm says its process extracts 90% of the phosphorus from sewage sludge and will displace imports from Russia and Morocco.

Kemira is expanding its coagulant capacity in Fredrikstad, Norway, in response to growing demand from water treatment utilities in Europe. It will add a reactor and build more storage for aluminum hydroxide.

Sumitomo Chemical is selling a 7% stake in Sumitomo Bakelite to the Singapore investment firm GIC for $160 million. Sumitomo says the sale is meant to strengthen its financial position so it can undertake structural reforms.

Abu Dhabi National Oil Co. has agreed to purchase a 35% stake in the clean hydrogen and ammonia complex that ExxonMobil plans to build in Baytown, Texas. ExxonMobil intends to make a final investment decision for the complex next year.

FSG has raised $100 million in a round led by the AMR Action Fund. The money will be used for clinical trials testing olorofim, an oral antifungal candidate. The US Food and Drug Administration rejected olorofim in 2023, requesting more data.

MinervaX ApS, a privately held Danish biotechnology company developing a vaccine against group B Streptococcus, has partnered with Wacker Biotech. Wacker will manufacture MinervaX’s active protein ingredients in the vaccine.